RPE SUSPENSION THERAPY
Eyestem’s Eyecyte-RPE trial shows vision rescue for geographic atrophy patientsEyestem will be presenting its data at the ARVO 2025 Annual Meeting as well as the 10th Retinal Cell and Gene Therapy Innovation Summit in ...
Eyestem completes first set of patient injections for Dry AMD treatmentEyestem Research has completed the first set of patient injections for its RPE suspension therapy aimed at treating Dry age-related macular...
Eyestem files for IND approval for its product to treat geographic atrophyEyestem Research has announced the submission of IND application to CDSCO to start first in-human trials of Eyecyte-RPE™for subjects.
Eyestem has a visionary approach to make cell therapy affordable in IndiaCell and gene therapy can go a long way in treating incurable diseases, but currently it is very pricey. Eyestem wants to dramatically cut ...
Load More